Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation

被引:8
|
作者
Yue WenTao [1 ]
Zhao XiaoTing [1 ]
Zhang LiNa [1 ]
Liu ZhiDong [2 ]
Ma Li [1 ]
Jia WenYun [1 ]
Qian Zhe [1 ]
Zhang ChunYan [1 ]
Wang Yue [1 ]
Yang XueHui [1 ]
Xu ShaoFa [2 ]
机构
[1] Capital Med Univ, Beijing Chest Hosp, Dept Cellular Biol, Beijing 101149, Peoples R China
[2] Capital Med Univ, Beijing Chest Hosp, Dept Thorac Surg, Beijing 101149, Peoples R China
关键词
CCNY; NSCLC; lentivirus RNAi; H1299; EXPRESSION; A1;
D O I
10.1007/s11427-010-0090-8
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cyclin Y (CCNY) is a key cell cycle regulator that acts as a growth factor sensor to integrate extracellular signals with the cell cycle machinery. The expression status of CCNY in lung cancer and its clinical significance remain unknown. The data indicates that CCNY may be deregulated in non-small cell lung cancer, where it may act to promote cell proliferation. These studies suggest that CCNY may be a candidate biomarker of NSCLC and a possible therapeutic target for lung cancer treatment.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 50 条
  • [1] Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation
    YUE WenTao1
    2 Department of Thoracic Surgery
    ScienceChina(LifeSciences), 2010, 53 (04) : 511 - 516
  • [2] Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation
    WenTao Yue
    XiaoTing Zhao
    LiNa Zhang
    ZhiDong Liu
    Li Ma
    WenYun Jia
    Zhe Qian
    ChunYan Zhang
    Yue Wang
    XueHui Yang
    ShaoFa Xu
    Science China Life Sciences, 2010, 53 : 511 - 516
  • [3] Cell Cycle Protein Cyclin Y Is Associated With Human Non-Small-Cell Lung Cancer Proliferation and Tumorigenesis
    Yue, Wentao
    Zhao, Xiaoting
    Zhang, Lina
    Xu, Shaofa
    Liu, Zhidong
    Ma, Li
    Jia, Wenyun
    Qian, Zhe
    Zhang, Chunyan
    Wang, Yue
    Yang, Xuehui
    CLINICAL LUNG CANCER, 2011, 12 (01) : 43 - 50
  • [4] Overexpression of MYCN promotes proliferation of non-small cell lung cancer
    Liu, Kun
    Wang, Shuo
    Liu, Yifei
    Gu, Jun
    Gu, Shudong
    Xu, Zhen
    Zhang, Rui
    Wang, Zhiwen
    Ma, Huaci
    Chen, Yingying
    Ji, Lili
    TUMOR BIOLOGY, 2016, 37 (09) : 12855 - 12866
  • [5] The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer
    Liu, Yafang
    Zhan, Ping
    Zhou, Zejun
    Xing, Ze
    Zhu, Suhua
    Ma, Chenhui
    Li, Qian
    Zhu, Qingqing
    Miao, Yingying
    Zhang, Jianya
    Lv, Tangfeng
    Song, Yong
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : 2911 - 2923
  • [6] Overexpression of CRKL Correlates With Poor Prognosis and Cell Proliferation in Non-Small Cell Lung Cancer
    Wang, Yan
    Dong, Qian-ze
    Fu, Ling
    Stoecker, Maggie
    Wang, Endi
    Wang, En-Hua
    MOLECULAR CARCINOGENESIS, 2013, 52 (11) : 890 - 899
  • [7] Overexpression of γ-tubulin in non-small cell lung cancer
    Maounis, Nicoletta F.
    Draberova, Eduarda
    Mahera, Eleni
    Chorti, Maria
    Caracciolo, Valentina
    Sulimenko, Tetyana
    Riga, Dimitra
    Trakas, Nikolaos
    Emmanouilidou, Aphrodite
    Giordano, Antonio
    Draber, Pavel
    Katsetos, Christos D.
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (09) : 1183 - 1194
  • [8] Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer
    Li, Lei
    Zeng, Ting-Ting
    Zhang, Bao-Zhu
    Li, Yan
    Zhu, Ying-Hui
    Guan, Xin-Yuan
    CANCER BIOLOGY & THERAPY, 2017, 18 (11) : 904 - 915
  • [9] Overexpression of CTEN is associated with gefitinib resistance in non-small cell lung cancer
    Lu, Xiangdong
    Zhang, Yao
    Pan, Yukai
    Cao, Minmin
    Zhou, Xie
    Zhang, Tingrong
    ONCOLOGY LETTERS, 2021, 21 (01) : 1 - 8
  • [10] Overexpression of ZIC5 promotes proliferation in non-small cell lung cancer
    Sun, Qi
    Shi, Run
    Wang, Xin
    Li, Demin
    Wu, Haiwei
    Ren, Binhui
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 479 (03) : 502 - 509